MicroRNA miR-125b is a prognostic marker in human colorectal cancer

Naohiro Nishida, Takehiko Yokobori, Koshi Mimori, Tomoya Sudo, Fumiaki Tanaka, Kohei Shibata, Hideshi Ishii, Yuichiro Doki, Hiroyuki Kuwano, Masaki Mori

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that can function as oncogenes or tumor suppressors in human cancer. Recent reports have highlighted the oncogenic aspects of microRNA miR-125b. However, the clinical significance of miR-125b in gastrointestinal cancers has not been sufficiently investigated. To this end, we analyzed miR-125b expression in colorectal cancer cases. Quantitative RT-PCR was used to evaluate miR-125b expression in 89 colorectal cancer cases to determine the clinicopathological significance of miR-125b expression. The high miR-125b expression group showed a greater incidence of advanced tumor size and tumor invasion compared to the low miR-125b expression group (P<0.05). In addition, the high miR-125b expression group had a significantly poorer prognosis compared to the low expression group (P<0.05). Multivariate analysis indicated that high miR-125b expression was an independent prognostic factor for survival. Our analysis of miR-125b focused on the miR-125b/p53 pathway. In vitro assays revealed that overexpression of miR-125b repressed the endogenous level of p53 protein in human colorectal cancer cells. These data show that miR-125b is directly involved in cancer progression and is associated with poor prognosis in human colorectal cancer. Our findings suggest that miR-125b could be an important prognostic indicator for colorectal cancer patients.

Original languageEnglish
Pages (from-to)1437-1443
Number of pages7
JournalInternational Journal of Oncology
Volume38
Issue number5
DOIs
Publication statusPublished - May 1 2011

Fingerprint

MicroRNAs
Colorectal Neoplasms
Neoplasms
Small Untranslated RNA
Gastrointestinal Neoplasms
Oncogenes
Multivariate Analysis
Polymerase Chain Reaction
Survival
Incidence
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

MicroRNA miR-125b is a prognostic marker in human colorectal cancer. / Nishida, Naohiro; Yokobori, Takehiko; Mimori, Koshi; Sudo, Tomoya; Tanaka, Fumiaki; Shibata, Kohei; Ishii, Hideshi; Doki, Yuichiro; Kuwano, Hiroyuki; Mori, Masaki.

In: International Journal of Oncology, Vol. 38, No. 5, 01.05.2011, p. 1437-1443.

Research output: Contribution to journalArticle

Nishida, N, Yokobori, T, Mimori, K, Sudo, T, Tanaka, F, Shibata, K, Ishii, H, Doki, Y, Kuwano, H & Mori, M 2011, 'MicroRNA miR-125b is a prognostic marker in human colorectal cancer', International Journal of Oncology, vol. 38, no. 5, pp. 1437-1443. https://doi.org/10.3892/ijo.2011.969
Nishida, Naohiro ; Yokobori, Takehiko ; Mimori, Koshi ; Sudo, Tomoya ; Tanaka, Fumiaki ; Shibata, Kohei ; Ishii, Hideshi ; Doki, Yuichiro ; Kuwano, Hiroyuki ; Mori, Masaki. / MicroRNA miR-125b is a prognostic marker in human colorectal cancer. In: International Journal of Oncology. 2011 ; Vol. 38, No. 5. pp. 1437-1443.
@article{3d1f5aa188c74a07969bc2a502b14b24,
title = "MicroRNA miR-125b is a prognostic marker in human colorectal cancer",
abstract = "MicroRNAs (miRNAs) are small, non-coding RNAs that can function as oncogenes or tumor suppressors in human cancer. Recent reports have highlighted the oncogenic aspects of microRNA miR-125b. However, the clinical significance of miR-125b in gastrointestinal cancers has not been sufficiently investigated. To this end, we analyzed miR-125b expression in colorectal cancer cases. Quantitative RT-PCR was used to evaluate miR-125b expression in 89 colorectal cancer cases to determine the clinicopathological significance of miR-125b expression. The high miR-125b expression group showed a greater incidence of advanced tumor size and tumor invasion compared to the low miR-125b expression group (P<0.05). In addition, the high miR-125b expression group had a significantly poorer prognosis compared to the low expression group (P<0.05). Multivariate analysis indicated that high miR-125b expression was an independent prognostic factor for survival. Our analysis of miR-125b focused on the miR-125b/p53 pathway. In vitro assays revealed that overexpression of miR-125b repressed the endogenous level of p53 protein in human colorectal cancer cells. These data show that miR-125b is directly involved in cancer progression and is associated with poor prognosis in human colorectal cancer. Our findings suggest that miR-125b could be an important prognostic indicator for colorectal cancer patients.",
author = "Naohiro Nishida and Takehiko Yokobori and Koshi Mimori and Tomoya Sudo and Fumiaki Tanaka and Kohei Shibata and Hideshi Ishii and Yuichiro Doki and Hiroyuki Kuwano and Masaki Mori",
year = "2011",
month = "5",
day = "1",
doi = "10.3892/ijo.2011.969",
language = "English",
volume = "38",
pages = "1437--1443",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - MicroRNA miR-125b is a prognostic marker in human colorectal cancer

AU - Nishida, Naohiro

AU - Yokobori, Takehiko

AU - Mimori, Koshi

AU - Sudo, Tomoya

AU - Tanaka, Fumiaki

AU - Shibata, Kohei

AU - Ishii, Hideshi

AU - Doki, Yuichiro

AU - Kuwano, Hiroyuki

AU - Mori, Masaki

PY - 2011/5/1

Y1 - 2011/5/1

N2 - MicroRNAs (miRNAs) are small, non-coding RNAs that can function as oncogenes or tumor suppressors in human cancer. Recent reports have highlighted the oncogenic aspects of microRNA miR-125b. However, the clinical significance of miR-125b in gastrointestinal cancers has not been sufficiently investigated. To this end, we analyzed miR-125b expression in colorectal cancer cases. Quantitative RT-PCR was used to evaluate miR-125b expression in 89 colorectal cancer cases to determine the clinicopathological significance of miR-125b expression. The high miR-125b expression group showed a greater incidence of advanced tumor size and tumor invasion compared to the low miR-125b expression group (P<0.05). In addition, the high miR-125b expression group had a significantly poorer prognosis compared to the low expression group (P<0.05). Multivariate analysis indicated that high miR-125b expression was an independent prognostic factor for survival. Our analysis of miR-125b focused on the miR-125b/p53 pathway. In vitro assays revealed that overexpression of miR-125b repressed the endogenous level of p53 protein in human colorectal cancer cells. These data show that miR-125b is directly involved in cancer progression and is associated with poor prognosis in human colorectal cancer. Our findings suggest that miR-125b could be an important prognostic indicator for colorectal cancer patients.

AB - MicroRNAs (miRNAs) are small, non-coding RNAs that can function as oncogenes or tumor suppressors in human cancer. Recent reports have highlighted the oncogenic aspects of microRNA miR-125b. However, the clinical significance of miR-125b in gastrointestinal cancers has not been sufficiently investigated. To this end, we analyzed miR-125b expression in colorectal cancer cases. Quantitative RT-PCR was used to evaluate miR-125b expression in 89 colorectal cancer cases to determine the clinicopathological significance of miR-125b expression. The high miR-125b expression group showed a greater incidence of advanced tumor size and tumor invasion compared to the low miR-125b expression group (P<0.05). In addition, the high miR-125b expression group had a significantly poorer prognosis compared to the low expression group (P<0.05). Multivariate analysis indicated that high miR-125b expression was an independent prognostic factor for survival. Our analysis of miR-125b focused on the miR-125b/p53 pathway. In vitro assays revealed that overexpression of miR-125b repressed the endogenous level of p53 protein in human colorectal cancer cells. These data show that miR-125b is directly involved in cancer progression and is associated with poor prognosis in human colorectal cancer. Our findings suggest that miR-125b could be an important prognostic indicator for colorectal cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=79955039593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955039593&partnerID=8YFLogxK

U2 - 10.3892/ijo.2011.969

DO - 10.3892/ijo.2011.969

M3 - Article

VL - 38

SP - 1437

EP - 1443

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -